Pharmacoeconomic guidelines: where do we go from here?
Berger
M
M
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D017408:Guidelines as Topic; D006302:Health Services Research / Q000191:economics / Q000379:methods*